Discovery of antitumor effects of leczymes
Glycoconjugate Journal · 2022-04 · 39 (2) · 157-165
DOI: 10.1007/s10719-021-10033-9 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Glycoconjugate Journal, online erschienen am 23.01.2022. Verfasst von Takeo Tatsuta und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cell Recognition, Institute of Molecular Biomembrane and Glycobiology, Tohoku Medical and Pharmaceutical University, 4-4-1 Komatsushima, …. Hauptthemen laut MEDLINE: Antineoplastic Agents, Apoptosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 85 Literaturangaben.
Abstract (Originalsprache)
Sialic-acid binding lectin from bullfrog (Rana catesbeiana) eggs, cSBL, is a cytotoxic ribonuclease (RNase) belonging to the RNase A superfamily. cSBL is cytotoxic to tumor cells, such as malignant pleural mesothelioma by inducing apoptotic cell death caused by the degradation of RNA in tumor cells. In addition, we have reported some data that cSBL could be involved in the endoplasmic reticulum stress pathway, and it was also assumed to cause apoptotic cell death. The most significant property of cSBL is its specificity toward malignant cells. Furthermore, since the antitumor activity of cSBL was confirmed by in vivo experiments using mouse xenograft models, it is expected to be a candidate for clinical chemotherapy. Here, we summarize the history of cSBL, alternatively called "leczyme," with its present and future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cell Recognition, Institute of Molecular Biomembrane and Glycobiology, Tohoku Medical and Pharmaceutical University, 4-4-1 Komatsushima, Aoba-ku, Sendai, 981-8558, Japan.
- Division of Cell Recognition, Institute of Molecular Biomembrane and Glycobiology, Tohoku Medical and Pharmaceutical University, 4-4-1 Komatsushima, Aoba-ku, Sendai, 981-8558, Japan. mhosono@tohoku-mpu.ac.jp.
ORCID-Profile: Masahiro Hosono
Zitieren
APA
Tatsuta, T., & Hosono, M. (2022). Discovery of antitumor effects of leczymes. Glycoconjugate Journal, 39(2), 157-165. https://doi.org/10.1007/s10719-021-10033-9
Vancouver
Tatsuta T, Hosono M. Discovery of antitumor effects of leczymes. Glycoconjugate Journal. 2022;39(2):157-165. doi:10.1007/s10719-021-10033-9
BibTeX
@article{Tatsuta2022,
author = {Tatsuta, Takeo and Hosono, Masahiro},
title = {Discovery of antitumor effects of leczymes},
journal = {Glycoconjugate Journal},
year = {2022},
volume = {39},
number = {2},
pages = {157--165},
doi = {10.1007/s10719-021-10033-9}
}
EUVIMED